Inhibrx Biosciences (INBX) closed at $71.78 on October 30, 2026, down 2.5% from the previous close, on volume of 431,950 shares (30-day average 270,461).
Data as of October 30, 2026.
30-Oct-2026
Analysts Are Bullish on These NA Stocks: MYR Group (MYRG), Inhibrx Biosciences Inc (INBX)
TipRanks (Thu, 29-Oct 9:30 AM ET)
Inhibrx Announces Participation in Upcoming Scientific Conferences
PRNewswire (Tue, 13-Oct 4:00 PM ET)
PRNewswire (Tue, 8-Sep 7:32 AM ET)
PRNewswire (Fri, 4-Sep 4:01 PM ET)
Inhibrx Reports Second Quarter 2026 Financial Results
PRNewswire (Thu, 13-Aug 4:05 PM ET)
Market Chameleon (Mon, 11-May 4:16 AM ET)
Market Chameleon (Wed, 22-Apr 3:34 AM ET)
Inhibrx Cuts R&D Costs Sharply as Two Clinical Trials Push Toward Key 2026 Milestones
Market Chameleon (Fri, 20-Mar 6:59 AM ET)
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Inhibrx Biosciences trades on the NASDAQ stock market under the symbol INBX.
As of October 30, 2026, INBX stock price declined to $71.78 with 431,950 million shares trading.
INBX has a beta of 3.55, meaning it tends to be more sensitive to market movements. INBX has a correlation of 0.16 to the broad based SPY ETF.
INBX has a market cap of $1.06 billion. This is considered a Small Cap stock.
In the last 3 years, INBX traded as high as $155.29 and as low as $10.80.
The top ETF exchange traded funds that INBX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.
INBX has underperformed the market in the last year with a price return of -8.6% while the SPY ETF gained +12.3%. INBX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.3% and -20.1%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
INBX support price is $70.18 and resistance is $77.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INBX shares will trade within this expected range on the day.
